期刊
ANTIBIOTICS-BASEL
卷 10, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/antibiotics10091046
关键词
antibiotics; neonatal intensive care unit; early-onset sepsis; late-onset sepsis; meningitis
资金
- NESTLE ESPANA S.A. [CIF A08005449, IP131304001]
Management of neonatal sepsis in European NICUs varies, with most units having clinical guidelines in place. The most commonly used antibiotics for EOS include ampicillin and gentamicin, while vancomycin, gentamicin, cefotaxime, and meropenem are frequently used for LOS. There is high adherence to local guidelines in EOS but less consistency in LOS antibiotic combinations.
Management of neonatal sepsis and the use of antimicrobials have an important impact on morbidity and mortality. However, there is no recent background on which antibiotic regimens are used in different European neonatal intensive care units (NICUs). Our study aimed to describe the use of antibiotics and other aspects of early- and late-onset sepsis (EOS and LOS, respectively) management by European NICUs. We conducted an online survey among NICUs throughout Europe to collect information about antibiotic stewardship, antibiotic regimens, and general aspects of managing neonatal infections. NICUs from up to 38 European countries responded, with 271 valid responses. Most units had written clinical guidelines for EOS (92.2%) and LOS (81.1%) management. For EOS, ampicillin, penicillin, gentamicin, and amikacin were the most commonly used antibiotics. Analysis of the combinations of EOS regimens showed that the most frequently used was ampicillin plus gentamicin (54.6%). For LOS, the most frequently used antibiotics were vancomycin (52.4%), gentamicin (33.9%), cefotaxime (28%), and meropenem (15.5%). Other aspects of the general management of sepsis have also been analyzed. The management of neonatal sepsis in European NICUs is diverse. There was high self-reported adherence to the local clinical guidelines. There was homogeneity in the combination of antibiotics in EOS but less in LOS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据